22 May 2026Open access
Thoracoabdominal esophageal duplication cyst in a 3-year-old girl: a case reportPublisher siteJournal of Pediatric Surgery Case Reports, Gastrointestinal disorders and treatments
Active, last published 2026
In gastrointestinal disorders and treatments
Aemon Berhane
Fissha
Scholar“Research focused on Gastrointestinal disorders and treatments and adjacent fields.”
Addis Ababa University
Ethiopia
Claim Your ProfileEthiopia0
H-index
0
Citations
Aemon has not officially claimed their profile. If you are Aemon, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
emon Berhane Fissha is a researcher working on Gastrointestinal disorders and treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Aemon's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Gastrointestinal disorders and treatments×2Intestinal Malrotation and Obstruction Disorders×1
04 · Where I am
Affiliations
Affiliation on published researchAddis Ababa University, EthiopiaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works9 May 2026Open access
Chilaiditi sign mimicking pneumoperitoneum with ischemic sigmoid volvulus: CT diagnosis of a surgical emergencyPublisher siteRadiology Case Reports, Intestinal Malrotation and Obstruction Disorders
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Aemon?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you